Pharmaceutical Manufacturing Plan for Africa is critical for pandemic preparedness, prevention and response


https://doi.org/10.4081/jphia.2023.2861
Vol 14, No 9 (2023) - September
Published: 28 September 2023
Pharmaceutical manufacturing in Africa, HIV, World Health Organisation, vaccine technology, healthcare systems, viral suppression, pandemic preparedness, pandemic response
Abstract Views: 736
PDF: 39
HTML: 2
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Michael Mynhardt
    michael.m@avacareglobal.com
    Group Executive at Avacare Health Global, Managing Director at Barrs Pharmaceutical Industries (Pty) Ltd, Ndabeni, Cape Town 7405, South Africa.
  • Nicaise Ndembi Chief Science Advisor, Office of the Director General of the Africa Center for Disease Control and Prevention (Africa CDC), Ethiopia.

The 12th International Aids Society Conference on HIV Science was recently held in Brisbane, Australia, featuring a number of studies that have come to represent several important advances in HIV prevention, treatment and cure research. The conference offered the World Health Organisation (WHO) an opportunity to announce that there is negligible, or almost zero risk of transmitting HIV when a person has an HIV viral load measurement of less than or equal to 1,000 viral load copies per ml, commonly referred to as having a suppressed viral load [...].


IAS 2023. International AIDS Society Conference. International AIDS Society. 2023. Available from: https://www.iasociety.org/conferences/ias2023

HIV.gov. Final IAS 2023 Conversations: HIV, STI Prevention, Stigma, and U=U. HIV.gov. July 26, 2023. Available from: https://www.hiv.gov/blog/final-ias-2023-conversations-hiv-sti-prevention-stigma-and-u-u/

World Health Organization. New WHO guidance on HIV viral suppression and scientific updates released at IAS 2023. Geneva: World Health Organization. July 23, 2023. Available from: https://www.who.int/news/item/23-07-2023-new-who-guidance-on-hiv-viral-suppression-and-scientific-updates-released-at-ias-2023

UNAIDS. Fact Sheet: Global HIV Statistics. Geneva: UNAIDS. 2023. Available from: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf

European Investment Bank. President of Senegal Macky Sall welcomes Team Europe support to help build a manufacturing plant in Senegal to produce vaccines against COVID-19 and other endemic diseases. Luxembourg: European Investment Bank. July 09, 2021. Available from:

https://www.eib.org/en/press/all/2021-254-president-of-senegal-macky-sall-welcomes-team-europe-support-to-help-build-a-manufacturing-plant-in-senegal-to-produce-vaccines-against-covid-19-and-other-endemic-diseases

Kanene, Z. The anti-HIV injection will be made in SA — it could cost between R600 and R800 a pop..Bhekisisa Centre for Health Journalism: Mail & Guardian. May 9, 2023 Available from: https://bhekisisa.org/article/2023-05-09-the-anti-hiv-injection-will-be-made-in-sa-it-could-cost-between-r600-and-r800-a-pop/

Mynhardt, M., & Ndembi, N. (2023). Pharmaceutical Manufacturing Plan for Africa is critical for pandemic preparedness, prevention and response. Journal of Public Health in Africa, 14(9). https://doi.org/10.4081/jphia.2023.2861

Copyright (c) 2023 the Authors

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC